InChI=1S/C22H32O4/c1- 3- 4- 7- 15(2) 20(23) 11- 10- 18- 19- 13- 16(8- 5- 6- 9- 22(25) 26) 12- 17(19) 14- 21(18) 24/h8,10- 11,15,17- 21,23- 24H,5- 7,9,12- 14H2,1- 2H3,(H,25,26) /b11- 10+,16- 8+/t15?,17- ,18+,19- ,20+,21+/m0/s1 |
HIFJCPQKFCZDDL-ACWOEMLNSA-N |
[H][C@]1(\C=C\[C@@H](O)C(C)CC#CC)[C@H](O)C[C@@H]2C\C(C[C@H]12)=C/CCCC(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
vasodilator agent
A drug used to cause dilation of the blood vessels.
|
|
View more via ChEBI Ontology
(5E)- 5- [(3aS,4R,5R,6aS)- 5- hydroxy- 4- [(1E,3S)- 3- hydroxy- 4- methyloct- 1- en- 6- yn- 1- yl]hexahydropentalen- 2(1H)- ylidene]pentanoic acid
|
iloprost
|
ChemIDplus
|
iloprostum
|
ChemIDplus
|
(16R,S)- methyl- 18,18,19,19- tetradehydro- 6a- carbaprostaglandin I2
|
ChemIDplus
|
4329060
|
Reaxys Registry Number
|
Reaxys
|
78919-13-8
|
CAS Registry Number
|
KEGG DRUG
|
14719835
|
PubMed citation
|
Europe PMC
|
15232651
|
PubMed citation
|
Europe PMC
|
15241524
|
PubMed citation
|
Europe PMC
|
19436672
|
PubMed citation
|
Europe PMC
|
|